Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence
- PMID: 20554798
- DOI: 10.1099/vir.0.020842-0
Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence
Abstract
The severity of respiratory syncytial virus (RSV) infections appears to differ with age in both humans and bovines. A primary RSV infection in naïve infants and in young calves runs a more severe course when they are 1-6 months old than in their first month of life. The relative lack of clinical signs in the first month of age may be due to high levels of maternally derived neutralizing antibodies or low exposure to infectious virus. This study examined whether age-dependent differences in the pathogenesis of bovine RSV (bRSV) between neonatal and young calves may be due to differences in age-dependent immunocompetence. To study the effect of age and immune parameters on bRSV disease in neonatal and young calves, neonatal (1-day-old) calves without maternally derived antibodies were infected experimentally with bRSV and the severity of disease and immune responses were evaluated in comparison with disease in similar 6-week-old infected calves. Neonatal calves had more extensive virus replication and lung consolidation, but lower pro-inflammatory [in particular tumour necrosis factor alpha (TNF-α)] responses, specific humoral immune responses, lung neutrophilic infiltration and clinical signs of disease than 6-week-old calves. The lack of correlation between virus replication and clinical signs suggests an important role of pro-inflammatory cytokines, in particular TNF-α, in the disease. The capacity to produce pro-inflammatory TNF-α appeared to increase with age, and may explain the age-dependent differences in RSV pathogenesis.
Similar articles
-
Age-dependent differences in cytokine and antibody responses after experimental RSV infection in a bovine model.Vaccine. 2005 May 16;23(26):3412-23. doi: 10.1016/j.vaccine.2005.01.094. Vaccine. 2005. PMID: 15837365
-
Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production.Comp Immunol Microbiol Infect Dis. 2006 Mar-May;29(2-3):138-56. doi: 10.1016/j.cimid.2006.03.002. Epub 2006 Apr 27. Comp Immunol Microbiol Infect Dis. 2006. PMID: 16644011
-
Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.J Am Vet Med Assoc. 2007 Jan 15;230(2):233-43. doi: 10.2460/javma.230.2.233. J Am Vet Med Assoc. 2007. PMID: 17223757 Clinical Trial.
-
[Immunobiology of bovine respiratory syncytial virus infections].Tijdschr Diergeneeskd. 1998 Nov 15;123(22):658-62. Tijdschr Diergeneeskd. 1998. PMID: 9836385 Review. Dutch.
-
Immunology of bovine respiratory syncytial virus infection of cattle.Comp Immunol Microbiol Infect Dis. 2012 May;35(3):253-7. doi: 10.1016/j.cimid.2012.01.005. Epub 2012 Mar 10. Comp Immunol Microbiol Infect Dis. 2012. PMID: 22410266 Review.
Cited by
-
A bovine respiratory syncytial virus model with high clinical expression in calves with specific passive immunity.BMC Vet Res. 2015 Mar 25;11:76. doi: 10.1186/s12917-015-0389-6. BMC Vet Res. 2015. PMID: 25890239 Free PMC article.
-
A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.Front Immunol. 2021 Apr 26;12:664212. doi: 10.3389/fimmu.2021.664212. eCollection 2021. Front Immunol. 2021. PMID: 33981309 Free PMC article.
-
Inflammatory responses to acute pneumovirus infection in neonatal mice.Virol J. 2010 Nov 15;7:320. doi: 10.1186/1743-422X-7-320. Virol J. 2010. PMID: 21078159 Free PMC article.
-
Detection of antibodies and risk factors for infection with bovine respiratory syncytial virus and parainfluenza virus 3 in dual-purpose farms in Colima, Mexico.Trop Anim Health Prod. 2012 Oct;44(7):1417-21. doi: 10.1007/s11250-012-0081-9. Epub 2012 Jan 21. Trop Anim Health Prod. 2012. PMID: 22270242
-
Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection.Vaccines (Basel). 2019 Jan 8;7(1):7. doi: 10.3390/vaccines7010007. Vaccines (Basel). 2019. PMID: 30626099 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical